Antibiotics for Hemodialysis Patients
For patients receiving hemodialysis, several antibiotics beyond vancomycin can be safely administered post-dialysis, including cefazolin, ceftazidime, cefepime, gentamicin (or tobramycin), ertapenem, and daptomycin, all dosed immediately after each dialysis session.
Empirical Therapy Options
For gram-positive coverage:
- Vancomycin: 20 mg/kg loading dose during the last hour of dialysis, then 500 mg during the last 30 minutes of each subsequent session 1
- Cefazolin: 20 mg/kg IV after each dialysis session (preferred in units with low methicillin-resistant staphylococci prevalence) 1
For gram-negative coverage:
- Gentamicin or tobramycin: 1 mg/kg (maximum 100 mg) after each dialysis session 1
- Ceftazidime: 1 g IV after each dialysis session 1
- Cefepime: Supported for thrice-weekly post-dialysis dosing 2, 3
Additional Post-Dialysis Antibiotics
Broader-spectrum options:
- Ertapenem: Evidence supports thrice-weekly post-dialysis administration 2, 3
- Daptomycin: Can be administered thrice-weekly after dialysis sessions 2, 3
Critical Timing Principle
All antibiotics must be administered immediately after dialysis completion, never before. Administering antibiotics before or during dialysis (except vancomycin during the final hour) results in significant drug removal and subtherapeutic levels 4. This timing ensures:
- Avoidance of premature drug removal 4
- Reliable pharmacodynamic target attainment 4
- Directly observed therapy for adherence 4
Antifungal Options
For Candida infections:
- Echinocandins: Caspofungin (70 mg IV loading, then 50 mg daily), micafungin (100 mg IV daily), or anidulafungin (200 mg IV loading, then 100 mg daily) 1
- Fluconazole: 200 mg orally daily 1
- Amphotericin B: Alternative option 1
Antibiotic Lock Therapy for Catheter Infections
For catheter-related bloodstream infections, combine systemic therapy with antibiotic lock solutions:
- Ceftazidime: 0.5 mg/mL with 100 IU/mL heparin 1, 4
- Cefazolin: 5.0 mg/mL with 2500-5000 IU/mL heparin 1
- Vancomycin: 2.5-5.0 mg/mL with heparin 1
- Gentamicin: 1.0 mg/mL with 2500 IU/mL heparin 1
- Ciprofloxacin: 0.2 mg/mL with 5000 IU/mL heparin 1
Common Pitfalls to Avoid
Do not reduce individual dose sizes; instead extend dosing intervals. This preserves concentration-dependent bactericidal activity 4. The standard approach for hemodialysis patients is to maintain full doses but space them to align with dialysis sessions (typically thrice-weekly) 1.
Avoid using peripherally inserted central catheters when possible. Utilize the existing hemodialysis vascular access for antibiotic administration to minimize complications including thrombosis, infection, and venous stenosis that could compromise future dialysis access 1, 3.
Do not assume intermittent hemodialysis dosing applies to other modalities. Patients receiving sustained low-efficiency dialysis (SLED) or continuous renal replacement therapy require different dosing strategies and are at high risk for underdosing 5, 6.
Selection Considerations
Base empirical gram-negative coverage on local antibiogram data rather than defaulting to a single agent 1. The choice between gentamicin, ceftazidime, or cefepime should reflect institutional resistance patterns and the suspected source of infection 1.
Consider the practical limitations of outpatient dialysis units, including limited drug formularies, absence of on-site pharmacy support, and geographic distance from hospitals 1. These factors often restrict antibiotic choices to vancomycin, cefazolin, and aminoglycosides despite the availability of other effective agents 7.